{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:10:46Z","timestamp":1778112646358,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04311-7","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:04:48Z","timestamp":1774656288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overcoming lysosomal barrier via V-ATPase: an exosome-based co-delivery platform for combined chemo\/RNAi therapy against breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Keyao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liefeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"1","key":"4311_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primer. 2019;5(1):66.","journal-title":"Nat Rev Dis Primer"},{"issue":"1","key":"4311_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol Mech Dis. 2022;17(1):181\u2013204.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"11","key":"4311_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"4311_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcis.2023.04.126","volume":"646","author":"M Cai","year":"2023","unstructured":"Cai M, Yao Y, Yin D, Zhu R, Fu T, Kong J, et al. Enhanced lysosomal escape of cell penetrating peptide-functionalized metal-organic frameworks for co-delivery of survivin siRNA and oridonin. J Colloid Interface Sci. 2023;646:370\u201380.","journal-title":"J Colloid Interface Sci"},{"issue":"6","key":"4311_CR5","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.ymthe.2024.04.007","volume":"32","author":"M Santhanam","year":"2024","unstructured":"Santhanam M, Kumar Pandey S, Shteinfer-Kuzmine A, Paul A, Abusiam N, Zalk R, et al. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression. Mol Ther. 2024;32(6):1934\u201355.","journal-title":"Mol Ther"},{"key":"4311_CR6","doi-asserted-by":"crossref","unstructured":"Friedrich M, Aigner A, Therapeutic, siRNA. State-of-the-Art and Future Perspectives. BioDrugs 2022;36(5):549\u2013571.","DOI":"10.1007\/s40259-022-00549-3"},{"issue":"1","key":"4311_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molmed.2023.10.005","volume":"30","author":"S Guo","year":"2024","unstructured":"Guo S, Zhang M, Huang Y. Three \u2018E\u2019 challenges for siRNA drug development. Trends Mol Med. 2024;30(1):13\u201324.","journal-title":"Trends Mol Med"},{"issue":"1","key":"4311_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, et al. Therapeutic siRNA: state of the art. Signal Transduct Target Ther. 2020;5(1):101.","journal-title":"Signal Transduct Target Ther"},{"key":"4311_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW, De Jong OG, Schiffelers RM, Andaloussi SE, et al. Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev. 2020;159:332\u201343.","journal-title":"Adv Drug Deliv Rev"},{"key":"4311_CR10","doi-asserted-by":"publisher","first-page":"103843","DOI":"10.1016\/j.redox.2025.103843","volume":"86","author":"D Han","year":"2025","unstructured":"Han D, Wang T, Li X, Qin C, Zhang Y, Zhou T, et al. Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis. Redox Biol. 2025;86:103843.","journal-title":"Redox Biol"},{"key":"4311_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jconrel.2023.10.007","volume":"363","author":"B Tao","year":"2023","unstructured":"Tao B, Du R, Zhang X, Jia B, Gao Y, Zhao Y, et al. Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy. J Controlled Release. 2023;363:692\u2013706.","journal-title":"J Controlled Release"},{"key":"4311_CR12","doi-asserted-by":"publisher","first-page":"144662","DOI":"10.1016\/j.ijbiomac.2025.144662","volume":"316","author":"T Yao","year":"2025","unstructured":"Yao T, Dong X, Wang X, Liu X, Fu L, Li L. Engineering exosomes for mRNA delivery: A review. Int J Biol Macromol. 2025;316:144662.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"4311_CR13","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s12276-025-01465-6","volume":"57","author":"K Lv","year":"2025","unstructured":"Lv K, Zhang Y, Yin G, Li X, Zhong M, Zhu X, et al. Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation. Exp Mol Med. 2025;57(6):1202\u201315.","journal-title":"Exp Mol Med"},{"issue":"10","key":"4311_CR14","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1039\/D3MH01030A","volume":"10","author":"M Cao","year":"2023","unstructured":"Cao M, Diao N, Cai X, Chen X, Xiao Y, Guo C, et al. Plant exosome nanovesicles (PENs): Green delivery platforms. Mater Horiz. 2023;10(10):3879\u201394.","journal-title":"Mater Horiz"},{"key":"4311_CR15","doi-asserted-by":"publisher","first-page":"106850","DOI":"10.1016\/j.jddst.2025.106850","volume":"107","author":"T Geng","year":"2025","unstructured":"Geng T, Ding L, Liu M, Zou X, Gu Z, Lin H, et al. Preservation of extracellular vesicles for drug delivery: A comparative evaluation of storage buffers. J Drug Deliv Sci Technol. 2025;107:106850.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"4311_CR16","doi-asserted-by":"publisher","first-page":"104070","DOI":"10.1016\/j.drudis.2024.104070","volume":"29","author":"A Ahmad","year":"2024","unstructured":"Ahmad A, Khan JM, Paray BA, Rashid K, Parvez A. Endolysosomal trapping of therapeutics and endosomal escape strategies. Drug Discov Today. 2024;29(8):104070.","journal-title":"Drug Discov Today"},{"issue":"4","key":"4311_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gut.2009.186528","volume":"59","author":"A Baghdasaryan","year":"2010","unstructured":"Baghdasaryan A, Claudel T, Kosters A, Gumhold J, Silbert D, Thuringer A, et al. Curcumin improves sclerosing cholangitis in Mdr2-\/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut. 2010;59(4):521\u201330.","journal-title":"Gut"},{"key":"4311_CR18","doi-asserted-by":"publisher","first-page":"0148","DOI":"10.34133\/research.0148","volume":"6","author":"C Qiu","year":"2023","unstructured":"Qiu C, Xia F, Zhang J, Shi Q, Meng Y, Wang C, et al. Advanced strategies for overcoming endosomal\/lysosomal barrier in nanodrug delivery. Research. 2023;6:0148.","journal-title":"Research"},{"issue":"45","key":"4311_CR19","doi-asserted-by":"publisher","first-page":"50896","DOI":"10.1021\/acsami.0c15781","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zu M, Ma X, Jia D, Lu Y, Zhang T, et al. Glutathione-responsive multifunctional trojan horse nanogel as a nanotheranostic for combined chemotherapy and photodynamic anticancer therapy. ACS Appl Mater Interfaces. 2020;12(45):50896\u2013908.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"4311_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12951-024-02859-w","volume":"22","author":"X Meng","year":"2024","unstructured":"Meng X, Shen Y, Zhao H, Lu X, Wang Z, Zhao Y. Redox-manipulating nanocarriers for anticancer drug delivery: A systematic review. J Nanobiotechnol. 2024;22(1):587.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"4311_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s40005-025-00731-z","volume":"55","author":"H Yuan","year":"2025","unstructured":"Yuan H, Chen Y, Hu Y, Li Y, Zhang H, Zhang S, et al. Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy. J Pharm Investig. 2025;55(6):889\u2013902.","journal-title":"J Pharm Investig"},{"key":"4311_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.omtn.2017.04.015","volume":"7","author":"W Chen","year":"2017","unstructured":"Chen W, Deng W, Goldys EM. Light-triggerable liposomes for enhanced endolysosomal escape and gene silencing in PC12 cells. Mol Ther - Nucleic Acids. 2017;7:366\u201377.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"4311_CR23","doi-asserted-by":"publisher","first-page":"144962","DOI":"10.1016\/j.ijbiomac.2025.144962","volume":"318","author":"Y Luo","year":"2025","unstructured":"Luo Y, Wang X, Li Y, Duan D, Liu K, Lei M, et al. Carrier-free nanotherapeutics unleashed: Ce6\/siPD-L1 co-delivery system synergizes photodynamic and RNAi therapies to combat breast cancer. Int J Biol Macromol. 2025;318:144962.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"4311_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/tra.12613","volume":"19","author":"F Wang","year":"2018","unstructured":"Wang F, G\u00f3mez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic. 2018;19(12):918\u201331.","journal-title":"Traffic"},{"key":"4311_CR25","doi-asserted-by":"publisher","first-page":"121415","DOI":"10.1016\/j.carbpol.2023.121415","volume":"323","author":"M Gao","year":"2024","unstructured":"Gao M, Deng H, Zhang Y, Wang H, Liu R, Hou W, et al. Hyaluronan nanogel co-loaded with chloroquine to enhance intracellular cisplatin delivery through lysosomal permeabilization and lysophagy inhibition. Carbohydr Polym. 2024;323:121415.","journal-title":"Carbohydr Polym"},{"issue":"2","key":"4311_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41580-019-0185-4","volume":"21","author":"A Ballabio","year":"2020","unstructured":"Ballabio A, Bonifacino JS. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2020;21(2):101\u201318.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"14","key":"4311_CR27","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1111\/febs.16768","volume":"290","author":"L Zhou","year":"2023","unstructured":"Zhou L, Ou S, Liang T, Li M, Xiao P, Cheng J, et al. MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy. FEBS J. 2023;290(14):3614\u201328.","journal-title":"FEBS J"},{"key":"4311_CR28","doi-asserted-by":"publisher","first-page":"105032","DOI":"10.1016\/j.chemphyslip.2020.105032","volume":"235","author":"F Ponti","year":"2021","unstructured":"Ponti F, Campolungo M, Melchiori C, Bono N, Candiani G. Cationic lipids for gene delivery: many players, one goal. Chem Phys Lipids. 2021;235:105032.","journal-title":"Chem Phys Lipids"},{"issue":"3","key":"4311_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","volume":"16","author":"JJ Rennick","year":"2021","unstructured":"Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021;16(3):266\u201376.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"4311_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/13880209.2024.2443424","volume":"63","author":"H Ye","year":"2025","unstructured":"Ye H, Wang Y, Zhang X, Yang L, Cai B, Zhang D, et al. Characterization of global research trends and prospects on celastrol, a principal bioactive ingredient of tripterygium wilfordii hook F: Bibliometric analysis. Pharm Biol. 2025;63(1):15\u201326.","journal-title":"Pharm Biol"},{"issue":"1","key":"4311_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00011-024-01983-5","volume":"74","author":"H Lei","year":"2025","unstructured":"Lei H, Ruan Y, Ding R, Li H, Zhang X, Ji X, et al. The role of celastrol in inflammation and diseases. Inflamm Res. 2025;74(1):23.","journal-title":"Inflamm Res"},{"issue":"1","key":"4311_CR32","doi-asserted-by":"publisher","first-page":"8508","DOI":"10.1038\/s41467-025-63472-5","volume":"16","author":"Y Huang","year":"2025","unstructured":"Huang Y, Dialynaki D, Lei Y, Zhang Z, Evans CR, Klionsky DJ. V-ATPase-dependent induction of selective autophagy. Nat Commun. 2025;16(1):8508.","journal-title":"Nat Commun"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04311-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04311-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04311-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:14:12Z","timestamp":1778109252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04311-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4311"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04311-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"420"}}